Ch IPreliminary
S.1 Short title and commencementS.2 DefinitionsS.3 Application and scopeCh IIObligations of Data Fiduciary
S.4 Grounds for processingS.5 NoticeS.6 ConsentS.7 Certain legitimate usesS.8 Data Fiduciary obligationsS.9 Children’s dataS.10 Significant Data FiduciaryCh IIIRights and duties of Data Principal
S.11 Right to accessS.12 Correction and erasureS.13 Grievance redressalS.14 Right to nominateS.15 Duties of the Data PrincipalCh IVSpecial provisions
S.16 Transfer outside IndiaS.17 ExemptionsCh VData Protection Board of India
S.18 Establishment of the BoardS.19 Composition of the BoardS.20 Salary and term of officeS.21 DisqualificationsS.22 Resignation and vacanciesS.23 Proceedings of the BoardS.24 Officers and employeesS.25 Members as public servantsS.26 Powers of the ChairpersonCh VIBoard powers and procedure
S.27 Powers and functions of the BoardS.28 Procedure followed by the BoardCh VIIAppeal and dispute resolution
S.29 Appeal to the Appellate TribunalS.30 Tribunal orders as a decreeS.31 Alternate dispute resolutionS.32 Voluntary undertakingCh VIIIPenalties
S.33 Penalties and the ScheduleS.34 Penalties to Consolidated FundCh IXMiscellaneous
S.35 Good-faith protectionS.36 Power to call for informationS.37 Blocking of accessS.38 Consistency with other lawsS.39 Bar of jurisdictionS.40 Power to make rulesS.41 Laying of rules before ParliamentS.42 Power to amend the ScheduleS.43 Power to remove difficultiesS.44 Amendments to other ActsDiagnostic centres generate some of the most revealing health data there is, and share it across patients, doctors and aggregators.
In short
Labs and diagnostic centres are Data Fiduciaries for test results, imaging and genetic data. The Act requires clear consent, minimal collection, secure sharing across every channel, and defined retention. Penalties reach ₹250 crore.
What changes for this sub-sector.
Consent to run a test is not automatic consent to share results with aggregators or to market to the patient.
Reports sent by SMS, email, portals or messaging apps must be secured and access-controlled.
Phlebotomy apps and sample-collection partners are processors you remain liable for.
Collect only what the test and report need; do not bundle unrelated data.
Keep results for the required clinical and legal period, then delete.
Patients can access and correct their results and withdraw consent for further use.
Niche guides for this area, each naming the specific regulation.
Secure your result-sharing channels and fix consent scope first.
The readiness check flags sharing-channel, consent-scope and retention gaps.
Take the readiness check →Consultant-led and partner-backed.